Eversept Partners’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-68,575
Closed -$1.72M 103
2021
Q1
$1.72M Sell
68,575
-134,753
-66% -$2.54M 0.13% 66
2020
Q4
$2.44M Buy
203,328
+6,300
+3% +$74.5K 0.29% 41
2020
Q3
$1.97M Buy
197,028
+44,815
+29% +$539K 0.44% 38
2020
Q2
$1.59M Buy
+152,213
New +$1.69M 0.22% 52

Other funds holding PRTA

Eversept Partners's PRTA Position: Q2 2021 in Review

Eversept Partners sold out of Prothena Corp (PRTA) in Q2 2021, closing a stake of 68,575 shares — an estimated $1.72M sold.

Eversept Partners first reported a position in PRTA in Q2 2020 and held it in 4 quarters. The position peaked at $2.44M in Q4 2020. 156 funds tracked by Wall St. Rank hold PRTA as of Q2 2021.

  • Eversept Partners reported no remaining Prothena Corp position as of Q2 2021 after selling out during the quarter.
  • Eversept Partners sold 68,575 Prothena Corp shares in Q2 2021, an estimated $1.72M.
  • Eversept Partners first reported a position in Prothena Corp in Q2 2020 and held it in 4 quarters.
  • Eversept Partners's Prothena Corp position peaked at $2.44M in Q4 2020.
  • 156 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2021.

Based on Eversept Partners's 13F filing for Q2 2021, filed 16 Aug 2021.